Research ArticleArticle
Flare Rate in Patients with Rheumatoid Arthritis in Low Disease Activity or Remission When Tapering or Stopping Synthetic or Biologic DMARD: A Systematic Review
T. Martijn Kuijper, Femke B.G. Lamers-Karnebeek, Johannes W.G. Jacobs, Johanna M.W. Hazes and Jolanda J. Luime
The Journal of Rheumatology November 2015, 42 (11) 2012-2022; DOI: https://doi.org/10.3899/jrheum.141520
T. Martijn Kuijper
From the Department of Rheumatology, Erasmus Medical Center, Rotterdam; Department of Rheumatology, Radboud University Medical Center, Nijmegen; Department of Rheumatology and Clinical Immunology, University Medical Center, Utrecht, the
Netherlands.
Femke B.G. Lamers-Karnebeek
Johannes W.G. Jacobs
Johanna M.W. Hazes
Data supplements
Data Supplement
Data Supplement
Files in this Data Supplement:
- Data Supplement - Data Supplement
In this issue
The Journal of Rheumatology
Vol. 42, Issue 11
1 Nov 2015
Flare Rate in Patients with Rheumatoid Arthritis in Low Disease Activity or Remission When Tapering or Stopping Synthetic or Biologic DMARD: A Systematic Review
T. Martijn Kuijper, Femke B.G. Lamers-Karnebeek, Johannes W.G. Jacobs, Johanna M.W. Hazes, Jolanda J. Luime
The Journal of Rheumatology Nov 2015, 42 (11) 2012-2022; DOI: 10.3899/jrheum.141520
Flare Rate in Patients with Rheumatoid Arthritis in Low Disease Activity or Remission When Tapering or Stopping Synthetic or Biologic DMARD: A Systematic Review
T. Martijn Kuijper, Femke B.G. Lamers-Karnebeek, Johannes W.G. Jacobs, Johanna M.W. Hazes, Jolanda J. Luime
The Journal of Rheumatology Nov 2015, 42 (11) 2012-2022; DOI: 10.3899/jrheum.141520